The largest database of trusted experimental protocols

Gapdh clone 14c10

Manufactured by Cell Signaling Technology
Sourced in United States

GAPDH (clone 14C10) is a primary antibody produced by Cell Signaling Technology. It targets the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein, which is a key enzyme involved in the glycolytic pathway.

Automatically generated - may contain errors

22 protocols using gapdh clone 14c10

1

Immunoblotting Analysis of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preparation of total cell lysates and Western blot analysis were performed as described previously [48 (link)]. Protein content was detected using Bradford method. SDS-PAGE electrophoresis, transfer, immunostaining, and ECL detection were carried out according to standard protocols of Bio-Rad Laboratories and antibody manufacturers. Primary antibodies against the following proteins were utilized: IGFBP3 (B-5, 1:500, from Santa Cruz Biotech.), phospho-p70S6 kinase (Thr389, 1:1000), phospho-S6 (Ser240/244, 1:1000), phospho-4E-BP1 (Thr37/46, 1:1000), phospho-ERK1/2 (Thr202/Tyr204, 1:2000), ERK2 (1:3000), phospho-Akt (Thr308, 1:700), Akt (1:1000), and GAPDH (clone 14C10, 1:4000) – all from Cell Signaling Technology. Secondary antibodies for immunoblotting – GAR-HRP (1:10000) and GAM-HRP (1:10000) were also from Cell Signaling Technology.
+ Open protocol
+ Expand
2

Caspase Activation and Pyroptosis Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPS was purchased from Santa Cruz Biotechnology, nigericin, and vildagliptin and Ac-YVAD-CMK from the Cayman Chemical Company, PMA and sitagliptin from Sigma, Ala-Pro-AFC from Bachem, saxagliptin from Toronto Research Chemicals, and Z-VAD-FMK and etoposide from Enzo Life Sciences. Val-boroPro45 (link), 1G24424 (link), FP-biotin15 (link), L-allo-Ile-isoindoline14 (link), and L-allo-Ile-thiazolidine14 (link) were synthesized according to previously published protocols. For cell culture experiments, Val-boroPro was resuspended in DMSO containing 0.1% TFA to prevent compound cyclization. Antibodies used include: human caspase-1 (#2225, Cell Signaling Technology), mouse caspase-1 (clone Casper-1, Adipogen), caspase-3 (clone 8G10, Cell Signaling Technology), human caspase-4 (clone 4B9, Santa Cruz), human caspase-5 (clone D3G4W, Cell Signaling Technology), caspase-7 (clone D2Q3L, Cell Signaling Technology), human IL-1β (Clone 2805, R&D Systems), mouse IL-1β (clone D4T2D, Cell Signaling Technology), IL-1α (#AF-200, R&D Systems), IL-18 (#AF2548, R&D Systems), GAPDH (clone 14C10, Cell Signaling Technology), DPP7 (Clone 398024, R&D Systems), DPP8 (ab42076, Abcam), DPP9 (ab42080, Abcam), PARP (#9542, Cell Signaling Technology), GSDMD (NBP2-33422, Novus Biologicals), DPP4 (#11D7, GeneTex), FAP (ABT11, Millipore), and SCPEP1 (SAB2700267, Sigma).
+ Open protocol
+ Expand
3

Synthesis and Characterization of Compound 8j

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compound 8j was synthesized according to previously published protocols29 (link). VbP (Talabostat mesylate) was purchased from R&D Systems and was resuspended in DMSO containing 0.1% TFA to prevent cyclization. Bortezomib was purchased from LC laboratories, zVAD-FMK from Ubpbio, VX-765 from Apexbio Technology LLC, and etoposide from Enzo Life Sciences. LPS (from E. coli O111:B4) was purchased from Invivogen, Nigericin from Cayman Chemicals, Bestatin Methyl Ester from Santa Cruz, and MCC950 from AdipoGen. Antibodies used were: hCASP1 (no. 2225, Cell Signaling Technology), GAPDH (clone 14C10, Cell Signaling Technology), hGSDMD (NBP2-3342, Novus Biologicals), PARP (no. 9542, Cell Signaling Technology), hNLRP1 (AF6788, R&D Systems), hCARD8 (no. ab24186, Abcam), mGSDMD (no. ab209845, Abcam), GSDMD (no. 219800, Abcam), α-Actin (no. A4700, Sigma-Aldrich), mCD45 (no. 103108, Biolegend, FITC conjugate, clone 30-F11), mCD3 (no. 100235, Biolegend, APC conjugate, clone 17A2), rCD3 (no. 201411, Biolegend, PE conjugate, clone 1F4), rCD6 (no. 554904, BD Biosciences, FITC conjugate, clone OX-52), mCaspase-1 (AG20B-0042, Adipogen), mIL-1β (no. D4T2D, Cell Signaling Technologies), NLRC4 (no. ab201792, Abcam), and NLRP3 (no. ab210491, Abcam).
+ Open protocol
+ Expand
4

Western Blotting: Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described previously (Borodkina et al., 2014 (link)). SDS-PAGE electrophoresis, transfer to nitrocellulose membrane and immunoblotting with ECL (Thermo Fisher Scientific, United States) detection were performed according to standard manufacturer’s protocols (Bio-Rad Laboratories, United States). Antibodies against the following proteins were used: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (clone 14C10) (1:1000, #2118, Cell Signaling Technology, United States), phospho-p53 (Ser15) (clone 16G8) (1:700, #9286, Cell Signaling Technology, United States), p21Waf1/Cip1 (clone 12D1) (1:1000, #2947, Cell Signaling Technology, United States), phospho-Rb (Ser 807/811) (1:1000, #8516, Cell Signaling Technology, United States), well as horseradish peroxidase-conjugated goat anti-rabbit IG (GAR-HRP, Cell Signaling Technology, United States) (1:10000).
+ Open protocol
+ Expand
5

Comprehensive Western Blotting Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described previously [22 (link)]. SDS-PAGE electrophoresis, transfer to nitrocellulose membrane and immunoblotting with ECL (Thermo Scientific, USA) detection were performed according to standard manufacturer’s protocols (Bio-Rad Laboratories, USA). Antibodies against the following proteins were used: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (clone 14C10) (1:1000, #2118, Cell Signaling, USA), phospho-p53 (Ser15) (clone 16G8) (1:700, #9286, Cell Signaling, USA), p21Waf1/Cip1 (clone 12D1) (1:1000, #2947, Cell Signaling, USA), phospho-Rb (Ser807/811) (1:1000, #8516, Cell Signaling, USA), phospho-ATM (Ser1981) (clone D6H9) (1:1000, #5883, Cell Signaling, MA, USA), phospho-Histone H2A.X (Ser139) (clone JBW301) (1:1000, #05-636, Merck Millipore, Germany), CD63 (1:500, ab68418, Abcam, UK), HSP70 (clone 2H9) (#MABE1130, Merck Millipore, Germany), PAI-1 (D9C4) (1:1000, #11907, Cell Signaling, USA) as well as horseradish peroxidase-conjugated goat anti-rabbit IG (GAR-HRP, Cell Signaling, USA) (1:10000) and antimouse IG (GAM-HRP, Cell Signaling, USA) (1:10000). Full size blots are provided in the Supplementary Figure 1.
+ Open protocol
+ Expand
6

Antibody Validation for UPR Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polyclonal antibodies for phosphorylated eIF2α (Ser51) and TBP (TATA-binding protein), as well as monoclonal antibodies for β-actin (clone 13E5) and GAPDH (clone 14C10), were purchased from Cell Signaling Technology (Danvers, MA, USA). Polyclonal antibodies for ATF6α and ATF4 (CREB2) were from Santa Cruz Biotechnology (Dallas, TX, USA). The antibody for ATF3 was purchased from GeneTex (Irvine, CA, USA), and the antibody for phosphorylated IRE1α (Ser724) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), N-(2-hydroxyethyl)-piperazine-N′-3-propanesulfonic acid (EPPS), 2-(4-morpholino)-ethanesulfonic acid (MES), and the protease inhibitor cocktail were from Sigma-Aldrich (St Louis, MO, USA) and Thermo Fisher Scientific (Waltham, MA, USA). The GPR4 inhibitor, 2-Ethyl-3-(4-((E)-3-(4-isopropyl-piperazin-1-yl)-propenyl)-benzyl)-5,7-dimethyl-3H-imidazo(4,5-b)pyridine, was purchased from Dalton Pharma Services (Toronto, ON, Canada).
+ Open protocol
+ Expand
7

Quantification of Glut9 Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed using 50-100 μg protein subjected to 10% SDS-PAGE, followed by transfer to nitrocellulose membrane and overnight primary antibody incubation24 (link)-25 (1:1000 dilutions at 4°C) with the following antisera: total Glut9, GAPDH (clone 14C10, Cell Signaling Technologies, Beverly MA), Glut9A14 (link) Actin (clone C4, EMD Millipore, Billerica, MA). Fixed (4% paraformaldehyde), paraffin-embedded intestinal sections were sectioned, permeablized in 0.1% triton X-100 in phosphate-buffered saline and blocked with 2% bovine serum albumin (Sigma-Aldrich, St. Louis, MO) prior to immunostaining using pre-immune serum or GLUT9-specific antibody (Generated in the laboratory of Dr. Annette Schürmann) at a 1:200 dilution.
+ Open protocol
+ Expand
8

Immunoblotting Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting analysis was performed as described previously [11 (link)]. SDS-PAGE electrophoresis, transfer to nitrocellulose membrane and immunoblotting with ECL (Thermo Scientific, CA, USA) detection were performed according to standard manufacturer’s protocols (Bio-Rad Laboratories, USA). Antibodies against the following proteins were used: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (clone 14C10) (1:1000, #2118, Cell Signaling, USA), phospho-Rb (Ser807/811) (1:1000, #8516, Cell Signaling, USA), phospho-p53 (Ser15) (clone 16G8) (1:700, #9286, Cell Signaling, USA), p21Waf1/Cip1 (clone 12D1) (1:1000, #2947, Cell Signaling, USA), phospho-ATM (Ser1981) (clone D6H9) (1:1000, #5883, Cell Signaling, USA), phospo-p38 (Thr180/Tyr182) (1:1000, #9211, Cell Signaling, USA) as well as horseradish peroxidase-conjugated goat anti-rabbit IG (1:10000, #7074, GAR-HRP, Cell Signaling, USA) () and antimouse IG (1:10000, #7076, GAM-HRP, Cell Signaling, USA) (). Hyperfilm (CEA) was from Amersham (Sweden). Equal protein loading was confirmed by Ponceau S (Sigma-Aldrich, USA) staining.
+ Open protocol
+ Expand
9

Comprehensive Protein and mRNA Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot was performed as previously described14 (link). Antibodies used: HA-Tag (Cell Signalling #3724; dilution 1:10,000); MITF (Thermo Fisher Scientific MA5-14146; dilution 1:1000); β-Actin (Cell Signalling #3700; dilution 1:2000); GAPDH (clone 14C10; Cell Signalling #2218; dilution 1:1000); CRYAB (Cell Signalling #45844s; dilution 1:1000).
RNA was extracted using NucleoSpin® RNA isolation kit from Macherey-Nagel (ref: 740955.240C). For patients and animal tissues a Trizol-based implementation of the NucleoSpin® RNA isolation kit protocol was used as reported14 (link). One microgram of total RNA was used for cDNA synthesis using MaximaTM H Minus cDNA Synthesis Master Mix (Invitrogen M1682). Quantitative Real-Time PCR (qRTPCR) was performed as previously described14 (link). Universal Probe Library (Roche) primers and probes employed are detailed in Supplementary Table 5. GAPDH (Hs02758991_g1) housekeeping assay from Applied Biosystems was used for data normalization.
For transcriptomics analysis in PC3 TRIPZ-HA-Flag-MITFA cells, Illumina whole genome -HumanHT-12_V4.0 (DirHyb, nt) method was used as reported14 (link). A hypergeometric test was used to detect enriched dataset categories.
+ Open protocol
+ Expand
10

Western Blot Analysis of T-PLL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed Western blots of whole-cell lysates of primary T-PLL cells and CD3+ pan T-cell isolated from age matched healthy controls by magnetic-bead based cell enrichment. Positive selection of CD3+ pan T-cells of healthy controls was performed according to the manufactures instruction (Biolegend). Following antibodies from Cell Signaling Technology were used in a 1:1000 dilution according to the manufacturer’s instruction: phospho-STAT5TYR694 (clone C11C5, catalogue #9359), STAT5 (polyclonal, #9363), and GAPDH (clone 14C10, #2118). As a secondary antibody we made use of HRP-coupled anti-rabbit (Dianova) in a 1:5000 dilution. Immunoblots were done using Western Bright ECL (Advansta, Menlo Park, CA, USA) and luminescence intensities were evaluated by densitometry (ImageJ software, National Institute of Health, Bethesda, MD, USA). Uncropped images of the immunoblots are displayed in Figure S5.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!